Dora Menchaca

Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo.

John J. Costa, George D. Demetri, Terence J. Harrist et al. · The Journal of Experimental Medicine · 1996 · 271 citations · Full text

Medicine, Dermatology, Immunology +13

Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer.

Russell L. Basser, John E.J. Rasko, Kerrie Clarke et al. · PubMed · 1997 · 201 citations

Medicine, Oncology, Chemotherapy +8

Peripheral Blood Progenitor Cell Mobilization Using Stem Cell Factor in Combination With Filgrastim in Breast Cancer Patients

John A. Glaspy, Elizabeth J. Shpall, C.F. LeMaistre et al. · Blood · 1997 · 147 citations · Full text

Medicine, Cell Biology, Oncology +12

Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factor.

R. Basser, L.B. To, C. Glenn Begley et al. · Journal of Clinical Oncology · 1998 · 34 citations

Medicine, Oncology, Pharmacotherapy +17